Treatment of intractable hyperemesis gravidarum by ondansetron

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 105, Issue 1, 2002, Pages 73-74

  Siu, Shing S N ^a   Yip, Shing Kai ^a   Cheung, Chun W ^a   Lau, Tze K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hyperemesis gravidarum; Ondansetron; Pregnancy

Indexed keywords

METOCLOPRAMIDE; ONDANSETRON; PROMETHAZINE;

ADULT; AMNIOCENTESIS; ARTICLE; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFECT; FEMALE; GESTATIONAL AGE; HUMAN; HYPEREMESIS GRAVIDARUM; MENTAL STRESS; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY TERMINATION; PREMATURITY; PRIORITY JOURNAL; SYMPTOM; VOMITING;

EID: 0037057965     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(02)00116-1     Document Type: Article

References (11)

1. Broussard C.N., Richter J.E. Nausea and vomiting of pregnancy. Gastroenterol. Clin. North Am. 27:1998;123-151.
2. Fairweather D.V.I. Nausea and vomiting in pregnancy. Am. J. Obstet. Gynecol. 102:1968;135-175.
3. Mazzotta P., Stewart D.E., Koren G., Magee L.A. Factors associated with elective termination of pregnancy among Canadian and American women with nausea and vomiting of pregnancy. J. Psychosom. Obstet. Gynaecol. 22:2001;7-12.
4. Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev 2000, CD000145.
5. Mazzotta P., Magee L.A., Maltepe C., Lifshitz A., Navioz Y., Koren G. The perception of teratogenic risk by women with nausea and vomiting of pregnancy. Reprod. Toxicol. 13:1999;313-319.
6. Wilde M.I., Markham A. Ondansetron: a review of its pharmacology and preliminary clinical findings in novel applications. Drugs. 52:1996;773-794.
7. Sullivan C.A., Johnson C.A., Roach H., Martin R.W., Stewart D.K., Morrison J.C. A pilot study of intravenous ondansetron for hyperemesis gravidarum. Am. J. Obstet. Gynecol. 174:1996;1565-1568.
8. Guikontes E., Spantideas A., Diakakis J. Ondansetron and hyperemesis gravidarum. Lancet. 340:1992;1223.
9. World M.J. Ondansetron and hyperemesis gravidarum. Lancet. 341:1993;185.
10. 3 antagonist ondansetron (Zofran). Postgrad. Med. J. 72:1996;688-689.
11. Tucker M.L., Jackson M.R., Scales M.D.C., Spurling N.W., Tweats K.J., Capel-Edwards K. Ondansetron: pre-clinical safety evaluation. Eur. J. Cancer Clin. Oncol. 25(Suppl 1):1989;S79-S93.